Key Features of the ACLP Program

By Mayo Clinic Staff

Clinical

  1. Holistic, patient-centered focus, from the outpatient setting through the transplant center
  2. Outstanding Blood and Marrow Transplantation Program
  3. Commitment to a partnership with referring physicians in caring for leukemia patients
  4. State-of-the-art facilities
  5. Access to world-class laboratory, radiographic, and pathology resources
  6. Myelodysplastic Syndrome Foundation Center of Excellence
  7. MPD Research Consortium Core Member

Research

  1. Part of the National Cancer Institute (NCI)-designated Mayo Comprehensive Cancer Center
  2. Part of the steering committee of the Eastern Cooperative Oncology Group Leukemia Committee
  3. Novel clinical trials in both chronic and acute leukemias. See Mayo Clinic clinical trials database for current trials.
  4. Involved in the Phase I new drug development program and, with it, access for leukemia patients to the newest therapies potentially helpful for their disease
  5. Banking of biological samples and tracking of leukemia therapy outcomes to advance the understanding of leukemia biology and treatment.
  6. Key role in Myeloproliferative Disorders Research Consortium and leadership on several trials

Educational

Host and/or sponsor of three educational events:

  • Annual Mayo Clinic Hematology CME conference each January, with a focus on the latest advances in leukemia diagnosis and therapy
  • Biennial National Meeting for Patients with Hematologic Cancers — Living with a Blood Disease Conference
  • Biennial Myeloproliferative Disorders Patient Symposium at Mayo Clinic in Arizona